374Water Seeks Shareholder Approval to Slash Authorized Shares 92.5% and Fix Exculpation Clause
SCWO sits 45% above its 52-week low of $1.75.
Summary
374Water's preliminary proxy asks shareholders to cut authorized shares from 1 billion to 75 million and fix an overbroad exculpation clause challenged in a Delaware class action, while disclosing $2.96M in director-participated convertible notes.
Key Events · Corporate Governance and Compliance · SCWO
-
Authorized Shares Cut 92.5%
Proposal 2 would reduce authorized common stock from 1,000,000,000 to 75,000,000 shares, aligning capital structure with the 1-for-10 reverse split and lowering Delaware franchise taxes, but limiting future equity issuance capacity.
-
Exculpation Clause Fixed to Moot Lawsuit
Proposal 3 amends Article EIGHT, Section A to conform to DGCL Section 102(b)(7), directly responding to the Rogers Action class action filed March 18, 2026, which alleged the existing provision was overbroad.
-
Director-Funded Convertible Notes Disclosed
The proxy reveals $2,960,000 in convertible notes issued March-July 2026 at 10% interest, convertible at $3.00/share with warrants at $4.50, including $800,000 from directors Freels, McKnight, and Pawloski.
-
Directors May Invest in Future Financings
Four directors — Weiser, Freels, McKnight, and Davis — are coordinating potential financing opportunities and may participate as investors, with aggregate amounts expected to exceed $120,000.
Analysis · SCWO · Manufacturing
The proxy statement reveals two governance changes with real consequences. Cutting authorized shares from 1 billion to 75 million aligns the capital structure with the post-reverse-split reality and reduces Delaware franchise taxes, but it also caps future equity issuance headroom at a time when the company faces going-concern doubts and relies on convertible notes and an ATM program for cash. The exculpation amendment is a direct response to the Rogers Action class action, which challenged the existing provision as overbroad; conforming it to DGCL Section 102(b)(7) moots the litigation and extends liability protection to officers. The filing also discloses $2.96 million in convertible notes issued since March, including $800,000 from three directors, and flags that four directors may participate in future financings — related-party transactions that raise governance questions amid the company's financial distress.
At the time of this filing, SCWO was trading at $2.53 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $44.3M. The 52-week trading range was $1.75 to $10.90. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.